samedan logo
 
 
spacer
home > pmps > spring 2021 > procurement in a pandemic – building resilience into the pharma supply chain for 2021
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Procurement in a Pandemic – Building Resilience into the Pharma Supply Chain for 2021

The impact of the pandemic has seen some sectors left redundant in the wake of national lockdowns, while others have needed to scramble to keep up with demand unlike anything they have witnessed before. The pharmaceutical sector has been instrumental to the survival of not only people, but the businesses that keep our world turning. Now, as positive news around vaccines and the arrival of the cavalry paints its efforts in a strong light, you’d be forgiven for overlooking the strains involved with getting to this position, and certainly, how these strains are set to evolve over the coming months (1).

In truth, pharma hasn’t been impervious to the impacts of COVID-19. It hasn’t been the sole floating market in a sea of drowning enterprises. Rather, it has been submerged in a different way. While others have scrambled to keep up with new trends, fluctuating demand, and ever-changing regulations, the pharma industry has needed to pivot and flex in order to support the world in its darkest hour. Domestic efforts have tied into a global effort to diagnose, treat, and prevent the virus from spreading – as well as face the knock-on effects of a stretched healthcare system.

As a result of this sudden, interconnected activity, and amid a deluge of expectation, the pharma supply chain has faced undeniable pressure. The events of this year have revealed substantial vulnerabilities within the discipline that must be overcome to realise the promise of a vaccine and respond to increasingly complex healthcare demands in 2021 and beyond.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Melaye Ras-Work co-founded Efficio Consulting in 2000 with Alex Klein, Jens Pedersen, and Juraj Priecel after beginning her career at AT Kearney. She oversees projects spanning several geographies to deliver breakthrough transformations of clients’ procurement and supply chain operations. She also is leading Efficio’s growth in France.
spacer
Melaye Ras-Work
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Envirotainer praises industry collaboration as it handles billionth vaccine

Stockholm, December 22, 2021: Envirotainer, the global market leader in secure cold-chain solutions for air transportation of pharmaceuticals, is calling for continued collaboration between pharmaceutical firms and the logistics industry.
More info >>

White Papers

High Potency Drugs – from Molecule to Market

PCI Pharma Services

PCI Pharma Services has invested in state-of-the-art containment equipment and created a ‘Potent Passport’ philosophy to identify the specific handling requirements for any Highly Potent Active Pharmaceutical Ingredients (HPAPI) project. Backed by 30 years’ experience of managing potent molecules, PCI Pharma Services is the logical choice when selecting an outsourcing partner.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement